Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-Cure in Ischemic Heart Failure
NCT00810238Phase 3Completed
- Sponsor
- Celyad Oncology
- Start
- Dec 2008
- Primary completion
- Jul 2010
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of C-Cure in heart failure (HF), ischemic cardiomyopathy (ICM), sponsored by Celyad Oncology. Started Dec 2008; status: completed.
02
Drugs
C-Cure
03
Conditions
heart failure (HF)ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT00810238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810238.